The LSM 880 with Airyscan confocal laser scanning microscope from Zeiss offers high sensitivity; enhanced resolution in x, y, and z; and high image-acquisition speed in a single system.
PDI has received FDA clearance for the Prevantics device swab, the only chlorhexidine gluconate/alcohol solution swab that has received market authorization from FDA for disinfecting needleless access sites prior to use on ports and hubs.
The BioT ULT Transporter from BioCision is an ultra-low temperature system designed for secure handling, freezing, and transporting of temperature-sensitive biomaterials.
Abbott Diagnostics has introduced the mView performance monitoring subscription for its m2000 molecular diagnostics system. The web-based dashboard offers configurable reports to automate data analysis and measure laboratory efficiency.
A new study in the journal Cancer finds that Myriad’s myRisk hereditary cancer test identifies 43% more patients with breast cancer risk.
The companies’ partners will take aim at transforming pathology workflow, addressing industry challenges related to case reporting, integration of molecular and genetic technologies, and synoptic reporting.
CLP’s September 2014 Tech Guide features a range of blood banking products from vendors such as Beckman Coulter, Helmer, HemoCue America, and Sysmex America.
A study presented at ICAAC 2014 finds that the clinical testing volume and positivity rate of the chikungunya virus both grew after the first case spread to the Western Hemisphere this year.
A new agreement with Premier enables Meridian to offer member facilities its Illumigene molecular diagnostic tests and instruments for C. difficile, Group B Streptococcus, Group A Streptococcus, B. pertussis, and M. pneumonia.
BluePrint proves superior to conventional subtyping for analyzing breast cancer before surgery, says a paper in the Annals of Surgical Oncology.